Methylprednisolone Completed Phase 4 Trials for Migraine Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00915473Greater Occipital Nerve Block for Migraine Prophylaxis